Page last updated: 2024-11-07

penicillamine and Antiphospholipid Syndrome

penicillamine has been researched along with Antiphospholipid Syndrome in 1 studies

Penicillamine: 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
penicillamine : An alpha-amino acid having the structure of valine substituted at the beta position with a sulfanyl group.

Antiphospholipid Syndrome: The presence of antibodies directed against phospholipids (ANTIBODIES, ANTIPHOSPHOLIPID). The condition is associated with a variety of diseases, notably systemic lupus erythematosus and other connective tissue diseases, thrombopenia, and arterial or venous thromboses. In pregnancy it can cause abortion. Of the phospholipids, the cardiolipins show markedly elevated levels of anticardiolipin antibodies (ANTIBODIES, ANTICARDIOLIPIN). Present also are high levels of lupus anticoagulant (LUPUS COAGULATION INHIBITOR).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Li, S1
Bai, Y1
Meng, J1
Wang, Q1
Tian, X1
Li, M1
Zeng, X1
Zhao, J1
Hu, C1

Other Studies

1 other study available for penicillamine and Antiphospholipid Syndrome

ArticleYear
Prevalence and diagnostic value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome in Chinese patients.
    Frontiers in immunology, 2023, Volume: 14

    Topics: Antibodies, Antiphospholipid; Antiphospholipid Syndrome; East Asian People; Female; Humans; Immunogl

2023